In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

The U.S. Food and Drug Administration has approved vimseltinib for adult patients with a rare condition called tenosynovial ...

Tea will be served at 10:15 a.m., immediately preceding the seminar.AudienceThis seminar is open to the research community.

Tea will be served at 10:15 a.m., immediately preceding the seminar.AudienceThis seminar is open to the research community.

The Aviram Lab investigates the molecular mechanisms that protect microorganisms from their own pathogenic invaders.

Tea will be served at 1:45 p.m., immediately preceding the seminar.AudienceThis seminar is open to the research community.

A five-year study has found that adding daratumumab (D) to the current standard-of-care triplet therapy bortezomib, lenalidomide, and dexamethasone (VRd) produced deeper and more durable minimal ...

We treat every type of cancer, including the most important one: yours. With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need ...

Thursday, March 20, 2025 - 2:00 p.m. to 3:00 p.m.